Syndicated Research

HRA's syndicated research programs provide an extremely robust exploration of key topics and audiences that are most influential in the medical market.  Utilizing qualitative and quantitative approaches among relevant stakeholders and key opinion leaders, HRA delivers actionable insights based on solid and reliable research. 
 
Our Strategic Syndicated Studies provide our clients with extensively researched, fact-based insights.  We start with extensive desk research to assess current market dynamics followed by exploratory qualitative research to validate assumptions and uncover new trends.  With these insights providing a strong foundation, we then design and conduct detailed quantitative research to provide reliable and fact-based perspectives.  A final qualitative validation phase among key opinion leaders corroborates key findings and provides forward-looking insights.
 
A unique feature of our Strategic Syndicated Research lies in our collaboration with clients – we do not create our research titles or survey instruments in a vacuum.  Rather, we offer our clients the ability to partner with us on the scope and design of these offerings, and to add proprietary questions that meet their specific needs.
 
HRA's Strategic Syndicated Research programs adopt a multi-client approach to primary market research – providing robust and deep insights on a number of markets, stakeholders, and business issues at a fraction of the cost of comparable custom research.  
 
Strategic Syndicated Study Approach
  • Robust exploration of key topics and audiences that are most influential in the healthcare market
  • Utilizes qualitative and quantitative approaches among relevant stakeholders and KOLs 
  • Conducted in partnership with clients to help meet their specific needs
  • Proprietary research method that goes deeper than other syndicated reports




Syndicated Reports
February 2016
In development: HRA's Latest Syndicated Initiative in Managed Care, released February 2016
May 2015
Discover the Impact on the Future of Oncology
January 2015
Gain insight into the future of incentive-driven pathway adherence and understand the impact of this practice and for pharmaceutical manufacturers
October 2014
Move beyond traditional account management models with strategic research from HRA
September 2014
The role of retail and specialty pharmacies is changing. Are you ready?